No Data
No Data
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
Express News | Accuray Appoints Michael Murphy as Vp, Corporate Controller
Accuray Appoints Michael Murphy as VP, Corporate Controller
Accuray's CyberKnife System Shows Disease Control, Safety in NEJM Study
Accuray Announced That Results Of The Pace-B– Prostate Advances In Comparative Evidence – Trial Were Published In The New England Journal Of Medicine
New England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men With Localized Prostate Cancer
No Data
No Data